The "Global Needle Free Injection System Market Analysis (2018-2024)" report has been added to ResearchAndMarkets.com's offering.
The Global Needle Free Injection System Market size is expected to reach $25 billion by 2024, rising at a market growth of 16.3% CAGR during the forecast period. As these systems improve the immune response to vaccines, eliminate risks of needles, and reduce healthcare costs, the demand for these systems has witnessed unprecedented demand. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration is expected to be factors that hamper the growth of this market.Growing cases of diabetes has driven the demand for needle-free insulin delivery devices globally. According to the Centers for Disease Control and Prevention, in 2015, approximately 30.3 million people or 9.4% of the total population of the U.S. suffered from diabetes. In addition, according to the Diabetes UK, in 2016, approximately 3.6 million people were diagnosed of diabetes in the UK. Therefore, growing diabetics is expected to propel the market growth.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), National Medical Product Inc, Valeritas Inc, European Pharma Group BV, Portal Instruments, Injex Pharma AG, Bioject Medical Technologies Inc.
Key Topics Covered
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.5 Methodology for the Research
Chapter 2. Market Overview
2.1 Introduction
2.2 Key Factors Impacting the Market
Chapter 3. Global Needle-free Injection Systems Market by Product
Chapter 4. Global Needle-free Injection Systems Market by Technology
Chapter 5. Global Needle-free Injection Systems Market by Type
Chapter 6. Global Needle-free Injection Systems Market by Site of Delivery
Chapter 7. Global Needle-free Injection Systems Market by Usability
Chapter 8. Global Needle-free Injection Systems Market by Application
Chapter 9. Global Needle-free Injection Systems Market by End User
Chapter 10. Global Needle-free Injection Systems Market by Region
10.1 Introduction
10.2 North America Needle-free Injection Systems Market
10.3 Europe Needle-free Injection Systems Market
10.4 Asia Pacific Needle-free Injection Systems Market
10.5 LAMEA Needle-free Injection Systems Market
Chapter 11. Company Profiles
11.1 Endo International PLC
11.2 Antares Pharma, Inc.
11.3 Pharmajet
11.4 Medical International Technology, Inc. (MIT)
11.5 Injex Pharma AG
11.6 National Medical Products, Inc.
11.7 Valeritas, Inc.
11.8 European Pharma Group B.V.
11.9 Portal Instruments
11.10 Bioject Medical Technologies Inc.
For more information about this report visit https://www.researchandmarkets.com/research/2xstlg/global_needle?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181121005204/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Medical
Devices, Infusions
and Injectables, Needles
and Syringes
